Rapid Absorption of Dry-Powder Intranasal Oxytocin

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Pharmaceutical Research

• Publication date

  2016-05-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11095-016-1929-xPMID 27194003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation

  2015cited by this paper
• Trends in Maternal Mortality: 1990 to 2015

  2015cited by this paper
• CSF and Blood Oxytocin Concentration Changes following Intranasal Delivery in Macaque

  2014cited by this paper
• Pulmonary Delivery of an Ultra-Fine Oxytocin Dry Powder Formulation: Potential for Treatment of Postpartum Haemorrhage in Developing Countries

  2013cited by this paper
• A new strategy to stabilize oxytocin in aqueous solutions: II. Suppression of cysteine-mediated intermolecular reactions by a combination of divalent metal ions and citrate.

  2012cited by this paper
• Nasal drug delivery

  2012cited by this paper
• A New Strategy to Stabilize Oxytocin in Aqueous Solutions: I. The Effects of Divalent Metal Ions and Citrate Buffer

  2011cited by this paper
• Nasal Delivery of High Molecular Weight Drugs

  2009cited by this paper
• Proposal for the inclusion of misoprostol in the WHO model list of essential medicines

  2009cited by this paper
• Epidemiology of postpartum haemorrhage: a systematic review.

  2008cited by this paper
• The Cochrane Database of Systematic Reviews

  2004cited by this paper
• Treatment for primary postpartum haemorrhage.

  2003cited by this paper
• Nasal Drug Delivery

  2003cited by this paper
• Bioavailability and Pharmacokinetics of Sublingual Oxytocin in Male Volunteers

  1995cited by this paper
• Comparative Aspects of Nasal Airway Anatomy: Relevance to Inhalation Toxicology*1

  1991cited by this paper
• Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccine.

  1990cited by this paper

• Pharmacokinetics of intranasal drugs, still a missed opportunity?

  2024cites this paper
• Animal models of postpartum hemorrhage

  2024influential citation
• A Comprehensive Review of Advanced Nasal Delivery: Specially Insulin and Calcitonin.

  2023cites this paper
• Effective nose-to-brain drug delivery using a combination system targeting the olfactory region in monkeys.

  2023cites this paper
• Development of a thermostable oxytocin microneedle patch.

  2021cites this paper
• Nanotechnologies for the delivery of biologicals: historical perspective and current landscape.

  2021cites this paper
• A Preliminary Examination of Endogenous Peripheral Oxytocin in a Pilot Randomized Clinical Trial of Oxytocin-Enhanced Psychotherapy for Posttraumatic Stress Disorder.

  2020cites this paper
• Retention of organic micro-pollutants by sorption processes

  2020cites this paper
• Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic

  2020cites this paper
• Evaluation of Systemic and Mucosal Immune Responses Induced by a Nasal Powder Delivery System in Conjunction with an OVA Antigen in Cynomolgus Monkeys

  2020cites this paper
• I Intranasal oxytocin affects the stress response to social isolation in sheep.

  2020cites this paper
• Augmenting Treatment for Posttraumatic Stress Disorder and Co-Occurring Conditions with Oxytocin

  2019cites this paper
• Protective Actions of Oxytocin on Aortic Wistar and SHR VSMCs

  2019cites this paper
• [Oxytocin in schizophrenia : Evidence for an etiological and therapeutic relevance of the social neuromodulator].

  2019cites this paper
• Effects of Intranasal Oxytocin on Pup Deprivation-Evoked Aberrant Maternal Behavior and Hypogalactia in Rat Dams and the Underlying Mechanisms

  2019cites this paper
• Systemic Delivery of Peptide Hormones Using Nasal Powders: Strategies and Future Perspectives

  2019cites this paper
• Oxytocin bei Schizophrenie

  2018cites this paper
• Overview of intranasally delivered peptides: key considerations for pharmaceutical development

  2018cites this paper
• Opportunity and challenges of nasal powders: Drug formulation and delivery

  2017cites this paper